BDBM426440 1-(2-((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8-yl)oxy) piperidine-1- carbonyl)phenyl) cyclopropanecarbonitrile::US10526336, Example 59

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2c(cnc12)C(F)(F)F

InChI Key InChIKey=XGNBFZFFJLSWRR-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 426440   

TargetOrexin receptor type 2(Human)
Merck, Sharp & Dohme

US Patent
LigandPNGBDBM426440(US10526336, Example 59 | 1-(2-((2R,5R)-2-methyl-5-...)
Affinity DataIC50: 12.8nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck, Sharp & Dohme

US Patent
LigandPNGBDBM426440(US10526336, Example 59 | 1-(2-((2R,5R)-2-methyl-5-...)
Affinity DataIC50: 4.38E+3nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
US Patent